Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Jul 2025 for SpringWorks Therapeutics, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
James Cassidy: trading record in brief
All filings by James Cassidy on record concern SpringWorks Therapeutics, Inc. The record holds 9 filings, for trades running from 5 January 2023 to 1 July 2025.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 2 July 2025 came the latest disclosure, a transaction in SpringWorks Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James Cassidy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
81,731 sharesCommon StockSEC:0001104659-25-065305:0
17,323 shares0Common StockSEC:0001104659-25-003461:0
4,325 shares@ US$38.1955.0% of flowCommon StockSEC:0001104659-25-001766:0
1,969 shares@ US$41.7125.4% of flowCommon StockSEC:0001104659-24-096360:0
591 shares@ US$38.537.3% of flowCommon StockSEC:0001104659-24-077347:0
28,208 shares0Common StockSEC:0001104659-24-002372:0
1,292 shares@ US$30.3312.4% of flowCommon StockSEC:0001104659-23-099291:0
5,720 sharesCommon StockSEC:0001104659-23-078086:0
22,663 sharesCommon StockSEC:0001104659-23-002320:0
9 of 9 declarations
